COVID-19 Surge in California Driven by New 'Stratus' Variant Tied to Omicron

COVID-19 cases are rising quickly in California, driven by the new 'stratus' omicron subvariant, with health officials warning about ongoing community transmission and delayed vaccine rollout. Learn the latest updates from experts.
COVID-19 cases are once again rising rapidly in California, signaling a concerning trend for public health officials. Recent data from wastewater analysis in Los Angeles and Santa Clara counties shows increased concentrations of the virus, alongside a slight uptick in hospitalizations and outpatient cases. Infectious disease experts, such as Dr. Peter Chin-Hong from UC San Francisco, emphasize that the surge is occurring later than last year but remains significant.
The positivity rates for COVID tests in Los Angeles County have increased to 12.6% as of mid-August, up from 7.6% a month earlier, while Orange County reports a rate of 14.4%, rising from 8.1%. Regional health leaders predict an escalation in COVID-19 cases among children, driven by the back-to-school season. Emergency room visits for COVID-like illnesses among seniors are also on the rise.
A predominant factor in this resurgence is the emergence of the 'stratus' subvariant of COVID-19, classified as an omicron subvariant, which accounts for most of the variants detected in wastewater. Dr. Hudson notes that previous infections with other omicron variants may provide some protection, but reinfections remain possible.
Although this summer's COVID-19 activity appears less severe than last year's peaks, the ongoing wave reflects a notable rise in community transmission. Hospitalizations in L.A. County are approximately half of what was recorded during the same period last year.
Complicating the situation is the delay in the federal rollout of the updated COVID-19 vaccine for fall, attributed to policy changes and licensure uncertainties. Health officials in California warn that the availability and timing of new vaccines may be later than usual, potentially impacting vaccination rates.
Given these developments, experts recommend that individuals at higher risk—such as those over 65, immunocompromised persons, pregnant women, and young children—consider getting vaccinated promptly. The vaccines are believed to still offer protection against severe illness, though the decision to vaccinate should be discussed with healthcare providers.
The delay and policy shifts reflect broader debates within the medical community about vaccine safety and effectiveness. Despite these challenges, vaccination remains a critical tool in preventing severe COVID-19 outcomes. Health authorities urge the public to stay informed about updates and to continue practicing preventive measures.
For more information, source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
New Insights into Hemoglobin’s Protective Role in Brain Cells Suggest Promising Therapeutic Strategies
New research reveals hemoglobin’s crucial antioxidant role in brain cells, opening innovative therapeutic strategies for neurodegenerative diseases and aging-related oxidative stress.
Kentucky Lawmaker Proposes Research into Psychedelic Substance Ibogaine as Potential Addiction Treatment
Kentucky's senator proposes studying ibogaine, a potent psychedelic, as a potential breakthrough in addiction treatment, aiming for FDA approval and expanded mental health options.
Analysis Reveals Poor Quality of Most-Viewed TikTok Videos on Inflammatory Bowel Disease
A study reveals that most highly viewed TikTok videos on inflammatory bowel disease lack medical accuracy, highlighting the need for healthcare professional engagement to improve content quality and patient education.
Innovative Growth-Compatible Heart Valve Shows Promise in Preclinical Trials for Young Children
A groundbreaking transcatheter heart valve developed at UC Irvine shows promising results in preclinical trials, potentially transforming early treatment for young children with congenital heart defects.